Table 1 Patient characteristics of the present study population
Characteristic | No. of patients (%) |
|---|---|
Median age, years (range) | 58.6 (23.5–89.2) |
Median CA-125 level at diagnosis, U/ml (range) | 490.5 (7–33439) |
Median nadir CA-125 level, U/ml (range) | 10 (4–35) |
Ethnicity | |
White | 316 (77.1) |
Black | 25 (6.1) |
Hispanic | 56 (13.7) |
Other* | 13 (3.2) |
Histology | |
Serous | 317 (77.3) |
Endometrioid | 42 (10.2) |
Clear cell | 18 (4.4) |
Mucinous | 9 (2.2) |
Transitional | 6 (1.5) |
Undifferentiated | 9 (2.2) |
MMMT | 9 (2.2) |
Grade | |
High | 361 (88.0) |
Low | 49 (12.0) |
FIGO stage | |
I | 42 (10.2) |
II | 31 (7.6) |
III | 284 (69.3) |
IV | 53 (12.9) |
Residual disease after primary surgery | |
Optimal (≤ 1 cm) | 322 |
Suboptimal (> 1 cm) | 65 |
Unknown | 23 |
NACT | |
Yes | 46 (11.2) |
No | 354 (86.3) |
Unknown | 10 (2.4) |